Vital KSK Holdings, Inc.

3151

JP3778280002

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
1,221 ^JPY	+1.58%		+3.91%	+16.95%

Feb. 07	Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024	CI
2023	Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023.	CI

Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

November 06, 2023 at 12:00 am EST

Vital KSK Holdings, Inc. provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the full year, the company expects net sales of JPY 576,000 million, operating profit of JPY 4,700 million and profit attributable to owners of parent of JPY 5,200 million or JPY 102.37 per basic share.

Latest news about Vital KSK Holdings, Inc.

Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024	Feb. 07	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023.	Nov. 07	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million.	Nov. 07	CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023	Nov. 06	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 06	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.	Nov. 06	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	Nov. 05	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	23-09-24	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million.	23-09-21	CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024	23-08-03	CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	23-08-03	CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-08-03	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	23-07-03	CI
Vital KSK Announces Voting Results	23-06-30	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 1,000,000 shares, for ¥1,200 million.	23-05-12	CI
Vital KSK Announces Notice Regarding Shareholder Proposal	23-05-12	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	23-05-11	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on June 21, 2022.	22-06-21	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on June 22, 2022, has closed with 1,500,000 shares, representing 2.82% of is issued share capital for ¥1,029 million.	22-06-21	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 1,500,000 shares, representing 2.82% for ¥1,029 million.	22-06-21	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	22-06-20	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on June 17, 2021.	22-01-31	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on June 17, 2021, has closed with 2,000,000 shares, representing 3.66% for ¥1,559.19 million.	22-01-27	CI

Chart Vital KSK Holdings, Inc.

Duration

Period

More charts

Company Profile

VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q4 2023 Earnings Release

More about the company

	1st Jan change	Capi.
VITAL KSK HOLDINGS, INC.	+16.95%	389M
MCKESSON CORPORATION	+17.35%	71.39B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	3.93B
GALENICA AG	-2.61%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.64B

Pharmaceuticals Wholesale